Japan
· Delayed Price · Currency is JPY Sundrug Statistics
Total Valuation
Sundrug has a market cap or net worth of JPY 497.53 billion. The enterprise value is 475.01 billion.
| Market Cap | 497.53B |
| Enterprise Value | 475.01B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Sundrug has 116.98 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 116.98M |
| Shares Outstanding | 116.98M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 4.61% |
| Owned by Institutions (%) | 27.81% |
| Float | 67.05M |
Valuation Ratios
The trailing PE ratio is 15.67 and the forward PE ratio is 14.66. Sundrug's PEG ratio is 2.62.
| PE Ratio | 15.67 |
| Forward PE | 14.66 |
| PS Ratio | 0.60 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | 46.20 |
| P/OCF Ratio | 11.51 |
| PEG Ratio | 2.62 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.52, with an EV/FCF ratio of 44.11.
| EV / Earnings | 14.96 |
| EV / Sales | 0.58 |
| EV / EBITDA | 7.52 |
| EV / EBIT | 10.52 |
| EV / FCF | 44.11 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.78 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 4.05 |
| Interest Coverage | 166.71 |
Financial Efficiency
Return on equity (ROE) is 11.80% and return on invested capital (ROIC) is 9.40%.
| Return on Equity (ROE) | 11.80% |
| Return on Assets (ROA) | 6.65% |
| Return on Invested Capital (ROIC) | 9.40% |
| Return on Capital Employed (ROCE) | 14.18% |
| Revenue Per Employee | 115.42M |
| Profits Per Employee | 4.44M |
| Employee Count | 7,145 |
| Asset Turnover | 1.89 |
| Inventory Turnover | 6.24 |
Taxes
In the past 12 months, Sundrug has paid 14.05 billion in taxes.
| Income Tax | 14.05B |
| Effective Tax Rate | 30.68% |
Stock Price Statistics
The stock price has increased by +13.47% in the last 52 weeks. The beta is 0.04, so Sundrug's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +13.47% |
| 50-Day Moving Average | 4,256.96 |
| 200-Day Moving Average | 4,428.35 |
| Relative Strength Index (RSI) | 45.92 |
| Average Volume (20 Days) | 273,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sundrug had revenue of JPY 824.66 billion and earned 31.75 billion in profits. Earnings per share was 271.43.
| Revenue | 824.66B |
| Gross Profit | 211.34B |
| Operating Income | 46.34B |
| Pretax Income | 45.80B |
| Net Income | 31.75B |
| EBITDA | 64.34B |
| EBIT | 46.34B |
| Earnings Per Share (EPS) | 271.43 |
Balance Sheet
The company has 66.14 billion in cash and 43.62 billion in debt, giving a net cash position of 22.52 billion or 192.52 per share.
| Cash & Cash Equivalents | 66.14B |
| Total Debt | 43.62B |
| Net Cash | 22.52B |
| Net Cash Per Share | 192.52 |
| Equity (Book Value) | 277.46B |
| Book Value Per Share | 2,371.78 |
| Working Capital | 97.03B |
Cash Flow
In the last 12 months, operating cash flow was 43.22 billion and capital expenditures -32.45 billion, giving a free cash flow of 10.77 billion.
| Operating Cash Flow | 43.22B |
| Capital Expenditures | -32.45B |
| Free Cash Flow | 10.77B |
| FCF Per Share | 92.05 |
Margins
Gross margin is 25.63%, with operating and profit margins of 5.62% and 3.85%.
| Gross Margin | 25.63% |
| Operating Margin | 5.62% |
| Pretax Margin | 5.55% |
| Profit Margin | 3.85% |
| EBITDA Margin | 7.80% |
| EBIT Margin | 5.62% |
| FCF Margin | 1.31% |
Dividends & Yields
This stock pays an annual dividend of 132.00, which amounts to a dividend yield of 3.10%.
| Dividend Per Share | 132.00 |
| Dividend Yield | 3.10% |
| Dividend Growth (YoY) | 0.77% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 47.88% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 3.09% |
| Earnings Yield | 6.38% |
| FCF Yield | 2.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sundrug has an Altman Z-Score of 5.01 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.01 |
| Piotroski F-Score | 6 |